Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Asset Utilization Ratio (2012 - 2026)

Updated

Oncotelic Therapeutics' Asset Utilization Ratio came in at 0.00 for Q2 2026.

Analysis

Oncotelic Therapeutics (OTLC) Asset Utilization Ratio (2012 - 2026) Analysis & Trends

Going back to Q4 2012, Oncotelic Therapeutics' Asset Utilization Ratio data covers 14 quarters.

  • Going back by year, Asset Utilization Ratio was 0.02 in FY2021 (-71.2%) and 0.07 in FY2020.
  • The Q2 2026 figure represents the highest quarterly Asset Utilization Ratio in data going back to Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 0.62
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 0.49
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 0.47
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 0.52
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 0.46
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 0.51
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 0.40
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 0.58
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 0.31
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Dec 31, 2021 0.02
Sep 30, 2021 0.02
Jun 30, 2021 0.02
Mar 31, 2021 0.08
Dec 31, 2020 0.07
Sep 30, 2020 0.07
Jun 30, 2020 0.08
Mar 31, 2020 0.02
Dec 31, 2013 0.02
Sep 30, 2013 0.02
Dec 31, 2012 0.03
API Access

Oncotelic Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=OTLC&period=max&api_key=YOUR_API_KEY